Secure your place at this valuable event today
BASINGSTOKE, UK, (May 18, 2009)
Oxoid, a world leading microbiology brand, is pleased to announce that the next Oxoid Infection Control Seminar will take place on 02 June 2009 at The Belfry, West Midlands, UK. This all-day event is completely free of charge and is provided as an educational service to consultant microbiologists, laboratory managers/personnel and infection control professionals.
This year’s topics and speakers include:
- An outbreak of the new superbug - MSSA (Dr Tim Boswell Nottingham University Hospital NHS Trust)
- The implications of PVL for infection control (Angela Kearns, Health Protection Agency)
- Implications and benefits of implementation of MRSA screening policy (Steve Farley and Yashpal Delele, Dudley Group of Hospitals NHS Trust)
- European Committee on Antimicrobial Susceptibility Testing (EUCAST) Update, (Gunnar Kahlmeter, Växjö Hospital, Sweden)
- New technology, friend or foe - how infection control needs are impacting hospital design (Martin Kiernan, President of the Infection Prevention Society)
- Standards and Performance Indicators for Healthcare Associate Infections and Antimicrobial Resistance in Europe (Professor Barry Cookson, Health Protection Agency).
This study day is accredited by the Institute of Biomedical Scientists (7 credits) and the Royal College of Pathologists (5 credits) and accreditation from the Royal College of Nursing has been sought.
The seminar is also a great opportunity to mix with colleagues and share current thinking on healthcare associated infection and infection control matters during the coffee and lunch breaks. So make sure you reserve the date and your FREE place by contacting Fiona Macrae, seminar manager, email: oxoid.awards@thermofisher.com tel: 01256 841144. Places are limited and are allocated on a first come, first served basis. Lunch is provided, but travel and accommodation are not included in this offer.
Oxoid is part of Thermo Fisher Scientific Inc., the world leader in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.